Researchers at the University of Pennsylvania’s School of Veterinary Medicine have engineered a lab-grown organoid that precisely mimics the development and function of the human adrenal cortex. This breakthrough provides a way to study a normally inaccessible tissue, offering a new path toward treating adrenal-related disorders and developing regenerative therapies for patients with adrenal insufficiency.
The adrenal glands—small, walnut-sized organs located atop the kidneys—are critical for maintaining the body’s homeostasis. They produce essential hormones, most notably cortisol, which allows the body to adapt to various stressors, including infection and emotional trauma. Despite their importance, the complexities of how these glands form and function have remained hard to replicate in a laboratory setting, which has historically slowed the development of targeted medical treatments.
A More Accurate Model of Human Biology
Previous attempts to model the adrenal gland often failed to replicate its complex organizational hierarchy or its ability to produce cortisol. The new system, led by Kotaro Sasaki and Michinori Mayama, uses human-induced pluripotent stem cells (iPSCs) and a stepwise growth process to create an organoid that faithfully recapitulates the prenatal functional zonation of the adrenal cortex.
Unlike simpler models, this organoid self-organizes into a layered, three-dimensional structure. It is functionally responsive, meaning it produces androgens and cortisol when triggered by adrenocorticotropic hormone (ACTH), the primary regulator secreted by the brain to control adrenal hormone production.
By preserving the characteristics of zona fasciculata cell lineages, these human adrenocortical organoids (ACOs) allow scientists to observe the gland’s development and dysfunction in real-time.
Research Context: The Role of Cortisol
Cortisol is a steroid hormone produced by the adrenal cortex. It regulates metabolism, reduces inflammation, and helps the body respond to stress. When the adrenal glands fail to produce enough cortisol—a condition known as primary adrenal insufficiency—patients may face life-threatening crises without hormone replacement therapy.
Implications for Disease Modeling and Regeneration
The ability to grow functional adrenal tissue in a lab opens two primary doors for clinical application: disease modeling and tissue regeneration.
For disease modeling, researchers have already used the platform to study Cushing’s syndrome. By introducing a specific pathogenic variant (PRKACA L206R), the team successfully modeled cortisol-producing adenomas, which could lead to a better understanding of how these tumors develop and how they might be treated.
The potential for regenerative medicine is equally significant. In preliminary tests, ACOs were able to secrete glucocorticoids in response to physiological stimuli and successfully rescue adrenalectomized mice. This suggests that these lab-grown tissues could one day be used to treat humans suffering from primary adrenal insufficiency, potentially reducing or eliminating the need for lifelong synthetic hormone injections.
Current Limitations and Next Steps
Although the rescue of mice is a promising proof of concept, the transition to human therapy remains a long-term goal. The research currently establishes the platform for exploring homeostasis and dysfunction. still, clinical application will require further study into the long-term stability and safety of implanted organoids in humans.
Understanding the Breakthrough
- What was created? A 3D human adrenocortical organoid derived from stem cells.
- Why is it different? It mimics the actual layered structure of the human gland and produces cortisol in response to ACTH, which previous models could not do.
- Who does this facilitate? It provides a tool for studying adrenal diseases like Cushing’s syndrome and offers a potential future treatment for those with adrenal insufficiency.
How might the ability to grow patient-specific endocrine tissues change the way we approach hormone-related disorders?
